Table 5 Univariate and multivariate logistic regression analyses of risk factors associated with PTDM occurrence.
Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
OR (95% CI) | P-value | OR (95% CI) | P-value | |
Baseline characteristics | ||||
Age | 1.08 (1.02–1.16) | 0.016 | ||
Male sex | 7.14 (1.43–35.57) | 0.016 | 17.45 (1.79–70.01) | 0.014 |
Baseline laboratory results | ||||
HbA1c | 4.78 (1.17–19.52) | 0.030 | ||
High-density lipids | 0.93 (0.89–0.98) | 0.010 | ||
Immunosuppression | ||||
3-Month tacrolimus AUC (ng/mL) | 1.01 (1.01–1.02) | 0.003 | ||
Postoperative CBGM | ||||
Mean glucose (mg/dL) | 1.03 (0.99–1.06) | 0.056 | ||
Mean daily peak glucose(mg/dL) | 1.03 (1.00–1.05) | 0.034 | ||
Postoperative CGM | ||||
Mean glucose (mg/dL) | 1.06 (1.02–1.11) | 0.003 | ||
Time above range of 180 mg/dL (%) | 1.11 (1.04–1.19) | 0.002 | 1.17 (1.06–1.29) | 0.002 |
Mean daily peak glucose (mg/dL) | 1.04 (1.01–1.06) | 0.004 | ||